S
Shigeaki Yoshida
Researcher at Tokyo Medical University
Publications - 194
Citations - 11574
Shigeaki Yoshida is an academic researcher from Tokyo Medical University. The author has contributed to research in topics: Cancer & Endoscopic mucosal resection. The author has an hindex of 48, co-authored 193 publications receiving 10855 citations. Previous affiliations of Shigeaki Yoshida include Universidad de La Sabana.
Papers
More filters
Journal ArticleDOI
Endoscopic mucosal resection for treatment of early gastric cancer
H Ono,H Kondo,Takuji Gotoda,Kuniaki Shirao,Hajime Yamaguchi,Daizo Saito,Koichi Hosokawa,Tadakazu Shimoda,Shigeaki Yoshida +8 more
TL;DR: Endoscopic mucosal resection allows us to perform less invasive treatment without sacrificing the possibility of cure, and submucosal invasion was found on subsequent pathological examination in 74 tumours.
Journal ArticleDOI
Appearance of enhanced tissue features in narrow-band endoscopic imaging.
Kazuhiro Gono,Takashi Obi,Masahiro Yamaguchi,Nagaaki Ohyama,Hirohisa Machida,Yasushi Sano,Shigeaki Yoshida,Yasuo Hamamoto,Takao Endo +8 more
TL;DR: The results of clinical tests in colonoscopy and esophagoscopy indicated that NBI will be useful as a supporting method for observation of the endoscopic findings of early cancer.
Journal ArticleDOI
A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video).
Yutaka Saito,Toshio Uraoka,Yuichiro Yamaguchi,Kinichi Hotta,Naoto Sakamoto,Hiroaki Ikematsu,Masakatsu Fukuzawa,Nozomu Kobayashi,Junichirou Nasu,Tomoki Michida,Shigeaki Yoshida,Hisatomo Ikehara,Yosuke Otake,Takeshi Nakajima,Takahisa Matsuda,Daizo Saito +15 more
TL;DR: ESD performed by experienced endoscopists is an effective alternative treatment to surgery, providing high en bloc and curative resection rates for large superficial colorectal tumors.
Journal ArticleDOI
Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)
Atsushi Ohtsu,Yasuhiro Shimada,Kuniaki Shirao,Narikazu Boku,Ichinosuke Hyodo,Hiroshi Saito,Noboru Yamamichi,Yoshinori Miyata,Nobumasa Ikeda,Seiichiro Yamamoto,Haruhiko Fukuda,Shigeaki Yoshida +11 more
TL;DR: Neither investigational regimen, FP nor UFTM, showed a survival advantage as compared with FU alone, althoughFP will remain a reference arm in a future trial for advanced gastric cancer.
Journal ArticleDOI
Definitive Chemoradiotherapy for T4 and/or M1 Lymph Node Squamous Cell Carcinoma of the Esophagus
Atsushi Ohtsu,Narikazu Boku,Kei Muro,Keisho Chin,Manabu Muto,Shigeaki Yoshida,Mitsuo Satake,Satoshi Ishikura,Takashi Ogino,Yoshinori Miyata,Shigeki Seki,Kazuhiro Kaneko,Akira Nakamura +12 more
TL;DR: Despite its significant toxicity, this combined modality seemed to have curative potential even in cases of locally advanced carcinoma of the esophagus.